RA Pharmaceuticals

Home » RA Pharmaceuticals

Secondary

RA Pharmaceuticals

Ra Pharmaceuticals is a clinical stage biopharmaceutical company focusing on the development of next-generation therapeutics for complement-mediated diseases.

Symbol

RARX

Last Closing Price
$6.71

Shares
500,000

Effective Date
February 27, 2018

Underwriters
Morgan Stanley

To view the prospectus for RA Pharmaceuticals, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253